|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Can peripartum cardiomyopathy be Familial显示文摘 | Baruteau AE Leurent G Sehleich JM | | 0，，02： | 1 |
| 2 | Characteristicsand long-term outcome of non-immune isolated atrioventricularblock diagnosed in utero or early childhood:amulticentre study显示文摘 | Baruteau AE Fouchard S Behaghel A | 2012 | Eur Heart J2012，33，5： | 1 |
| 3 | Transcatheter closure of patent ductus arteriosus:past, present and future显示文摘 | Baruteau AE Hascoet S Baruteau J | 2014 | Arch Cardiovasc Dis2014，107，2： | 1 |
| 4 | Parental electro- cardiographic screening identifiesa high degree of inheritance for congenital and childhood nonimmune isolated atrio-ventricular block显示文摘 | Baruteau AE Behaghel A Fouchard S | 2012 | Circulation2012，126，： | 1 |
| 5 | Dorsolumbar kyphosis:diagnostic value of hook shaped vertebra显示文摘 | Baruteau J De Baulny HO | | 0，，5： | 1 |
| 6 | Inherited progressive cardiac conduction disorders显示文摘 | Baruteau AE Probst V Abriel H | 2015 | Curr Opin Cardiol2015，30，1： | 1 |
| 7 | Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives显示文摘 | Baruteau AE Leurent G Martins RP | 2010 | Int J Cardiol2010，144，1： | 1 |
| 8 | Peripartum cardiomyopathyin the CTa of cardiac magnetic resonance imaging:first results andpCTspectives显示文摘 | Baruteau AE Leurent G Martins RP | | Int J Cardiol0，144，1： | 1 |
| 9 | Contribution of cardiac MRI in the comprehension of peripartum cardiomyopathy pathogenesis显示文摘 | Leurent G Baruteau AE Larralde A | 2009 | Int J Cardiol2009，132，3： | 1 |
| 10 | Can peripartum cardiomyopathy be Familial显示文摘 | Baruteau AE Leurent G Sehleich JM | 2009 | Int J Cardiol2009，137，2： | 1 |
| 11 | Contribution of cardiac MRI in the comprehension of peripartum cardiomyopathy pathogenesis显示文摘 | Leurent G Baruteau AE Larralde A | 2009 | Int J Cardiol2009，132，3： | 1 |
| 12 | Peripartum cardiomyop-athy in the era of cardiac magnetic resonance imaging: first resultsand perspectives显示文摘 | Baruteau AE Leurent G Martins R | 2010 | Int J Cardiol2010，144，1： | 1 |
| 13 | Long QT syndrome: an underestimated cause of sudden infant death显示文摘 | Baruteau AE Baruteau J Baruteau R | 2009 | Arch Pediatr2009，16，4： | 1 |
| 14 | Long QT syndrome:an underestimated cause of sudden infant death显示文摘 | Baruteau AE Baruteau J Baruteau R | 2009 | Arch Pediatr2009，16，4： | 1 |
| 15 | Transcatheter closure of patent ductus arteriosus:Past,present and future显示文摘 | Baruteau AE Hascoet S Baruteau J | 2014 | Arch Cardiovasc Dis2014，107，2： | 1 |
| 16 | Can peripartum car- diomyopathy be familial? 显示文摘 | Baruteau AE Leurent G Schlelch JM | 2009 | Int J Cardiol2009，137，： | 1 |
| 17 | Parental electrocardiographic screening identifies a high degree of inheritance for congenital and childhood nonimmune isolated atfioventrieular bhick显示文摘 | Baruteau AE Behaghel A Fouchard S | 2012 | Circulation2012，126，12： | 1 |
| 18 | Efficacy,Safety and Characteristics of the Amplatzer Vascular Plug II and IV Utilization for Various Percutaneous Occlusions in Children under 10 Years显示文摘Objectives:We aim to describe the efficacy,safety,and characteristics of the Amplatzer Vascular Plug(AVP)II and IV“off-label”use for multiple cardiovascular occlusions in children under 10 years.Methods:Observational retrospective multicenter(2007–2020,6 centers)review of paediatric procedures using AVP II or IV.Results:A total of 125 children(49.6%aged≤1 year,147 lesions)underwent 136 successive procedures(success rate:98.5%)using 169 devices(109 AVP IV,60 AVP II).The mean device diameter was 7.7±3.2 mm(4–20 mm).The median AVP size to vessel diameter ratio was 1.3(0–2).The median age and weight at implantation were 1.0 year(0.01–9.98)and 8.4 kg(1–69).Procedures were heterogeneous(55 patent ductus arteriosus(PDA),28 collaterals,18 sequestrations,22 arteriovenous/veinovenous/coronary fistulas,6 vertical veins,6 conduits,5 ventricular septal defects,7 miscellaneous).Day 1 and 6-month occlusion rates were respectively 94.8%and 98.5%.Major adverse events(MAE)occurred in 5.2%of cases(no procedure-related deaths),and more frequently in weight≤5 kg(p=0.01),younger patients(p=0.03)during PDA closure(p=0.02)of tubular types(p=0.02)using larger devices(p=0.03)and AVP II(p=0.003).Independent predictor of MAE risk was a higher AVP diameter to patient weight ratio(Odds-ratio:2.33,95%confidence interval 1.31–4.13,p=0.004,optimal cut off:1.45).Conclusions:Both AVPs are safe and effective for percutaneous occlusions in children under 10.Such devices represent an alternative“off label”use for well selected paediatric patients. | Hugues Lucron Alban-Elouen Baruteau Caroline Ovaert Ali Houeijeh Mélanie Brard Patrice Guerin François Bourlon Claire Dauphin Saskia Tuttle Maha Tagorti Rishika Banydeen François Godart | 2022 | Congenital Heart Disease2022，17，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员